BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 31722716)

  • 1. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
    Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
    Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
    Wang Q; Zhang Q; Sun H; Tang W; Yang L; Xu Z; Liu Z; Jin H; Cao X
    Dig Dis Sci; 2019 Mar; 64(3):751-758. PubMed ID: 30519852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
    Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
    BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 gene.
    Liu ZH; Yang SZ; Li WY; Dong SY; Zhou SY; Xu S
    Aging (Albany NY); 2021 Jan; 13(8):12179-12193. PubMed ID: 33504681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Role of a Novel Long Noncoding RNA
    Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
    Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
    [No Abstract]   [Full Text] [Related]  

  • 9. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis.
    Shi Y; Fang N; Li Y; Guo Z; Jiang W; He Y; Ma Z; Chen Y
    Cancer Sci; 2020 Aug; 111(8):2824-2836. PubMed ID: 32495982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma.
    Shi Y; Guo Z; Fang N; Jiang W; Fan Y; He Y; Ma Z; Chen Y
    Biomed Pharmacother; 2019 Sep; 117():109151. PubMed ID: 31229921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
    Gao A; Su Z; Shang Z; He C; Miao D; Li X; Zou S; Ding W; Zhou Y; Sun M; Zhou J
    Cell Death Dis; 2022 Oct; 13(10):900. PubMed ID: 36289198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of circRNA Regulators MBNL1 and QKI in the Progression of Esophageal Squamous Cell Carcinoma.
    Wang HF; Zhou XF; Zhang QM; Wu JQ; Hou JH; Xu XL; Li XM; Liu YL
    Cancer Control; 2024; 31():10732748241257142. PubMed ID: 38769028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
    Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification.
    Liang Y; Mao Q; Wang L; Xia W; Chen B; Wang H; Li R; Xu L; Jiang F; Dong G
    Clin Transl Med; 2021 Sep; 11(9):e519. PubMed ID: 34586741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
    Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
    J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
    Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
    Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
    Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.